This content is only available within our institutional offering.
26 Sep 2018
LIBERUM: Croda - Amarin's US trial breakthrough could trigger a new lease of life for Pharma grade Omega3
Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
LIBERUM: Croda - Amarin's US trial breakthrough could trigger a new lease of life for Pharma grade Omega3
Croda International Plc (CRDA:LON) | 2,755 -192.9 (-0.3%) | Mkt Cap: 3,847m
- Published:
26 Sep 2018 -
Author:
Adam Collins -
Pages:
3 -